The Global PET MRI Systems Market, valued at USD 138.7 Million in 2025, is projected to exhibit a CAGR of 9.5%, reaching USD 261.8 Million by 2032.

Market growth is primarily driven by the rising demand for advanced hybrid imaging technologies that combine functional and anatomical imaging for enhanced diagnostic accuracy. Increasing applications of PET-MRI in oncology, neurology, and cardiology, along with the growing prevalence of cancer and neurological disorders, are fueling adoption worldwide.

Moreover, continuous technological advancements—such as AI-enabled image reconstruction, improved detector technologies, and reduced radiation exposure—are expanding the clinical utility of these systems. Supportive regulatory frameworks, rising healthcare investments, and the integration of PET-MRI in research and precision medicine are expected to further propel the market expansion over the forecast period.

Market Takeaways

• By Phase, Preclinical PET-MRI systems are expected to dominate the market with a 58.4% share in 2025, driven by the growing use of hybrid imaging in biomedical research, drug development, and translational studies. The ability of PET-MRI to provide high-resolution anatomical and functional insights makes it increasingly valuable in preclinical research applications.
• By Type, Traditional PET-MRI systems are projected to lead the market with a 64.7% share in 2025, supported by their widespread clinical adoption, proven reliability, and established use in oncology, neurology, and cardiology imaging. However, helium-free PET-MRI systems are expected to gain traction due to their lower maintenance requirements and operational cost advantages.
• By End User, Hospitals contribute the maximum share in 2025, owing to their advanced diagnostic infrastructure, growing patient pool for cancer and neurological disorders, and integration of hybrid imaging modalities for comprehensive disease management.
• Regionally, North America is expected to hold the largest market share in 2025, driven by strong healthcare investments, high adoption of advanced imaging technologies, and the presence of key market players and research institutions promoting hybrid imaging innovation.

Global PET MRI Systems Market Report Coverage

The full report is now available for purchase: https://www.coherentmi.com/industry-reports/pet-mri-systems-market

Report Coverage	Details
Market Revenue in 2025	USD 138.7 Million
Estimated Value by 2032	USD 261.8 Million
Growth Rate	Poised to exhibit a CAGR of 9.5%
Historical Data	2020-2024
Forecast Period	2025–2032
Forecast Units	Value (USD Million)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	By Phase, Type, and End User
Geographies Covered	North America (U.S. and Canada), Latin America (Brazil, Argentina, Mexico, and Rest of Latin America), Europe (Italy, Spain, U.K., Germany, France, Russia, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific), Middle East (GCC Countries, Israel, and Rest of Middle East), and Africa (South Africa, North Africa, and Central Africa)
Growth Drivers	Increasing Number of Alzheimer's Disease, Strokes, and Other Neurological Conditions Cancer Burden Driving PET MRI Adoption
Trends	AI-Enabled Image Reconstruction & Workflow Optimization Expansion in Neurology, Pediatric, and Soft-Tissue Applications
Opportunities	Continuous R&D Efforts Leading to Better Imaging Capabilities Increasing Approvals of New Devices by Regulatory Authorities
Restraints & Challenges	Extremely High Pricing of PET MRI Systems Other Imaging Modalities, such as CT or Standalone MRI

Market Dynamics

The global PET MRI systems market is witnessing robust growth, driven by increasing demand for advanced hybrid imaging technologies that combine the anatomical precision of MRI with the metabolic insights of PET. The growing prevalence of cancer, neurological, and cardiovascular diseases has accelerated the adoption of PET-MRI systems in both clinical and research settings. Continuous advancements in imaging software, detector technology, and workflow automation are further enhancing diagnostic accuracy and efficiency, supporting greater clinical utilization.

Technological innovations are playing a pivotal role in reshaping the market landscape. Developments such as helium-free PET-MRI systems, AI-powered image reconstruction, and quantitative imaging analytics are improving image quality, reducing operational costs, and streamlining diagnostic processes. Preclinical PET-MRI systems are witnessing particularly high demand from research institutions and pharmaceutical companies for drug discovery, biomarker validation, and translational research. Meanwhile, clinical systems are expanding their presence in hospitals for oncology, neurology, and cardiology applications.

However, high system costs, limited availability of trained operators, and the need for advanced infrastructure remain key challenges restricting wider adoption, particularly in developing regions. Despite these constraints, the market outlook remains positive, supported by increasing R&D investments, strategic collaborations among imaging technology providers, and expanding applications in personalized medicine and molecular diagnostics. These factors are expected to drive sustainable market growth through 2032.

Market Trends

• AI-Enabled Image Reconstruction & Workflow Optimization

Artificial intelligence (AI) and machine learning are increasingly integrated into PET-MRI systems to enhance image reconstruction speed, improve lesion detection, and automate workflow processes. These technologies help reduce scan times, minimize artifacts, and deliver higher diagnostic accuracy. AI-driven tools also assist clinicians in quantitative analysis and protocol standardization, improving efficiency and enabling broader adoption of PET-MRI in both clinical and research settings.

In December 2024, Siemens Healthineers unveiled its recent PET/MR scanner BIOGRAPH One at RSNA 2024, which incorporates AI-powered image reconstruction and streamlined workflow features (e.g., Deep Resolve, large axial FOV PET detector, simplified patient-slot time).

• Expansion in Neurology, Pediatric, and Soft-Tissue Applications

PET-MRI systems are gaining traction beyond oncology, expanding into neurology, pediatric imaging, and soft-tissue assessment due to their superior anatomical and functional imaging capabilities. In neurology, PET-MRI enables precise mapping of brain metabolism and connectivity, supporting early diagnosis of Alzheimer’s and Parkinson’s disease. In pediatrics, reduced radiation exposure makes PET-MRI safer for children. Additionally, its high soft-tissue contrast is driving adoption in musculoskeletal and cardiovascular imaging applications.

At the May ISMRM 2024 conference, an abstract titled “Hybrid Positron Emission Tomography and MRI (PET-MRI) with [18F]FDG for identifying musculoskeletal pain generators: Early experience” described how PET/MRI is being applied in musculoskeletal/soft-tissue imaging (chronic back pain, hip pain) for identifying pain generators.

Market Opportunities

• Point-of-Care and Mobile Hybrid Imaging Solutions

With healthcare increasingly shifting toward decentralized care settings, there is an opportunity for mobile or portable PET-MRI systems designed for ambulatory care centres, mobile imaging vans, and community hospitals. These systems allow providers to bring advanced hybrid imaging closer to patients, reduce travel burden, and increase scan throughput in underserved regions.

• Sustainability-Driven Equipment Designs (Helium-Free & Energy-Efficient Scanners)

As healthcare providers face rising energy costs and regulatory pressure on greenhouse gas emissions, system vendors can differentiate through PET-MRI platforms that use helium-free magnet technology, lower power consumption, and carbon-efficient designs. Such “green” scanners align with institutional ESG goals and may unlock faster procurement cycles in regions prioritizing sustainability.

In May 2023, Philips introduced its BlueSeal Magnet for MR operations, marking a major sustainability milestone as the industry’s first 1.5 T fully sealed magnet. The system requires only 0.5% of the helium used in conventional MRI scanners, significantly reducing helium dependency, maintenance needs, and infrastructure costs while supporting environmentally sustainable imaging operations.

Analyst View

• The global PET MRI systems market is expected to witness sustained growth through 2032, driven by the convergence of advanced imaging technologies, clinical demand for multimodal diagnostics, and ongoing integration of artificial intelligence. Analysts observe that hybrid PET-MRI is rapidly transitioning from niche research use to mainstream clinical adoption, as healthcare providers increasingly value its combined anatomical and metabolic imaging precision in complex disease assessment.
• From a technology standpoint, analysts highlight that continuous advancements in detector performance, helium-free magnet design, and AI-assisted image reconstruction are reshaping operational efficiency and diagnostic capabilities. The evolution toward fully sealed, energy-efficient magnets—such as Philips’ BlueSeal—and AI-powered image analysis from Siemens Healthineers and GE HealthCare are collectively improving workflow automation, lowering maintenance requirements, and enhancing image quality while supporting sustainability and cost optimization.
• From a clinical application perspective, analysts note a broadening use of PET-MRI beyond oncology into neurology, cardiology, and pediatrics. Its superior soft-tissue contrast and lower radiation exposure are making it a preferred modality for early-stage Alzheimer’s detection, pediatric imaging, and musculoskeletal evaluations. Expanding research in molecular imaging, precision oncology, and neurodegenerative disorders further reinforces PET-MRI’s role in translational and personalized medicine.
• Competitively, the market is characterized by strong participation from established imaging players such as Siemens Healthineers, GE HealthCare, Philips, and United Imaging, alongside emerging innovators focused on compact, mobile, and research-grade PET-MRI systems. Strategic collaborations between academic institutions, hospitals, and technology developers are accelerating innovation in both preclinical and clinical domains, with a growing emphasis on AI-based analytics and workflow integration.
• Opportunities remain robust in decentralized and sustainable imaging solutions, including point-of-care PET-MRI units and helium-free, low-power scanners. Analysts expect these innovations to appeal particularly to healthcare systems in resource-constrained and sustainability-driven regions. Additionally, increasing regulatory approvals, funding for hybrid imaging research, and expanding clinical evidence supporting PET-MRI’s diagnostic value are expected to sustain market momentum.
• Overall, analysts maintain a positive outlook on the PET MRI Systems Market through 2032. The sector stands at the intersection of AI innovation, clinical precision, and environmental sustainability. Companies that can effectively integrate advanced imaging software, cost-efficient hardware, and application-specific clinical solutions are likely to secure a competitive advantage in this fast-evolving hybrid imaging landscape.

Key Development

• In March 2023, Bruker Corporation showcased its BioSpec Maxwell 94/17 PET/MRI system, highlighting integrated advances in preclinical MRI and PET technologies. The demonstration featured neuroimaging applications ranging from anatomical imaging to molecular event mapping and included a live workflow session covering study setup, data acquisition, visualization, and PET-MRI data registration using PMOD software.

Competitive Landscape

• Siemens Healthineers AG
• GE Healthcare
• Bruker Corporation
• Mediso Ltd
• MR Solutions
• United Imaging Healthcare Co., Ltd.
• Koninklijke Philips N.V.
• Cubresa Inc.
• Inviscan Imaging Systems
• Canon Medical Systems Corporation

PET MRI Systems Market Segmentation

• By Phase
• Preclinical
• Clinical
• By Type
• Traditional PET-MRI Systems
• Helium-Free PET-MRI Systems
• By End User
• Hospitals
• Diagnostic Centers
• Academic & Research Institutes
• Others

Regional Insights

• North America
  • U.S.
  • Canada
• Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America
• Europe
  • Italy
  • Germany
  • U.K.
  • Spain
  • France
  • Russia
  • Rest of Europe
• Asia Pacific
  • South Korea
  • India
  • Japan
  • China
  • Australia
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of the Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa